LFCR vs RCL · rev $75.5M vs P/E 26, rev $9.28B
Lifecore Biomedical Inc. (LFCR) versus Royal Caribbean Cruises Ltd (RCL) — a side-by-side from cached financials, not a winner call.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Royal Caribbean Cruises Ltd (RCL) is a travel services company listed on US.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
Latest reported RCL revenue for 2026-06-30 was $9.28B. Net income was $2.07B. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
LFCR currently screens at market cap $207.1M. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
Not investment advice. Open the LFCR and RCL stock pages for the full models.
Not investment advice.